LobbyingFoundation Medicine lobbying by quarter
Foundation Medicine's latest lobbying report covers Q2 2026, at $160K. The four quarters Q4 2025–Q3 2026 total $480K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Foundation Medicine
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $480K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $160K | 2 |
| Q1 2023 | $180K | 2 |
| Q2 2023 | $160K | 2 |
| Q3 2023 | $170K | 2 |
| Q4 2023 | $170K | 2 |
| Q1 2024 | $190K | 2 |
| Q2 2024 | $210K | 2 |
| Q3 2024 | $170K | 2 |
| Q4 2024 | $160K | 2 |
| Q1 2025 | $160K | 2 |
| Q2 2025 | $160K | 2 |
| Q3 2025 | $160K | 2 |
| Q4 2025 | $160K | 2 |
| Q1 2026 | $160K | 2 |
| Q2 2026 | $160K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$1.7M · 29 reports
- Medicare and Medicaid$551.7K · 16 reports
- Trade$133.3K · 5 reports
- Budget and appropriations$53.3K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- SENATE26 reports
- HOUSE OF REPRESENTATIVES25 reports
- Food & Drug Administration (FDA)12 reports
- Centers For Medicare and Medicaid Services (CMS)5 reports
- Homeland Security, Dept of (DHS)4 reports
- White House Office2 reports
- Executive Office of the President (EOP)1 reports
- Natl Institutes of Health (NIH)1 reports
- U.S. Customs & Border Protection1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseFoundation Medicine | $1.3M | 15 quarters |
| Tarplin, Downs & Young | $1.2M | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| CHARLOTTE SPEARS IVANCIC | Leg. Counsel, Sen. Jim DeMint; Health Counsel, Maj. Leader Bill Frist; Counsel and Budget Analyst, House Budget Cmte.; Asst. to the Speaker for Policy, Speaker John Boehner | Q2 2026 |
| ELIZABETH T MURRAY | Senior Policy Advisor, Democratic Whip Steny Hoyer; Legislative Asst. for Rep. Mike Thompson, Rep. Bob Matsui, and Senator Bob Graham | Q2 2026 |
| EMILY H MURRY | Staff Dir., Sub. Cmte. on Health, W&M Cmte; Sr. Policy Advisor, Majority Leader McCarthy; Policy Advisor, Majority Whip McCarthy; Professional Staff, Republican Study Cmte.; Leg. Aid, Rep. Ken Calvert; Leg. Asst., Rep. Tom Price | Q2 2026 |
| JENNIFER B YOUNG | Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff, Sen. Cmte. on Finance | Q2 2026 |
| MARGARET JOSEPH | CoS for Sen. Kyrsten Sinema, CoS for Rep. Kyrsten Sinema, CoS for Rep. Bobby Bright, CoS for Rep. Jim Matheson, Clerk for House Rules Cmte. | Q2 2026 |
| PAMELA SMITH | Leg. Dir., Sen. Tom Harkin; Dep. Staff Dir., Senate HELP Cmte; Staff Dir., Senate HELP Cmte; Counselor to the Asst. AG, Civil Div., Dept. of Justice; Spec Counsel, Ofc of Leg. Affairs, Dept. of Justice; Counsel and LA, Senator Carol Moseley-Braun | Q2 2026 |
| PARICK BRAERTON CARROLL | Leg Asst. Rep. Ray LaHood, Leg Dir. Rep. Kevin Yoder, PSM Senate Appropriations Cmte. | Q2 2026 |
| PETER FISE | Health Counsel for Sen. Cmte on Finance, Health Counsel for Sen. Jeanne Shaheen, Staff Assistant for House Cmte on Oversight & Government Reform | Q2 2026 |
| RAISSA H DOWNS | Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Staff Dir., Sub. Cmte. on Employment, Sen. HELP Cmte. | Q2 2026 |
| LAURA FRIEDEL | Leg. Asst., Sen. Zell Miller, Leg. Dir., Sen. Richard Shelby, Clerk, Staff Dir., Sen. Appropriations Committee | Q3 2025 |
| KIMBERLY LYNN BRANDT | Sr. Counsel and Dir. External Affairs - HHS OIG; Prin. Dep. Administrator for Policy and Operations and Dir. of Medicare Program Integrity - CMS; Chief Oversight and General Counsel - Senate Cmte. on Finance | Q4 2024 |
| MICHELLE P EASTON | Chief Health Counsel, Sen. Cmte. on Finance; Staff Dir., Senate Aging Cmte.; Leg. Asst., Congressman Billy Tauzin | Q4 2022 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/16for Q2 | Tarplin, Downs & Young | $80K |
| 07/16for Q2 | In-house | $80K |
| 04/20for Q1 | Tarplin, Downs & Young | $80K |
| 04/16for Q1 | In-house | $80K |
| 01/20for Q4 2025 | Tarplin, Downs & Young | $80K |
| 01/15for Q4 2025 | In-house | $80K |
| 25/10/17for Q3 2025 | In-house | $80K |
| 25/10/16for Q3 2025 | Tarplin, Downs & Young | $80K |
| 25/07/18for Q2 2025 | In-house | $80K |
| 25/07/16for Q2 2025 | Tarplin, Downs & Young | $80K |
| 25/04/18for Q1 2025 | In-house | $80K |
| 25/04/16for Q1 2025 | Tarplin, Downs & Young | $80K |
| 25/01/21for Q4 2024 | In-house | $80K |
| 25/01/16for Q4 2024 | Tarplin, Downs & Young | $80K |
| 24/10/18for Q3 2024 | Tarplin, Downs & Young | $80K |
| 24/10/16for Q3 2024 | In-house | $90K |
| 24/07/16for Q2 2024 | Tarplin, Downs & Young | $80K |
| 24/07/12for Q2 2024 | In-house | $130K |
| 24/04/22for Q1 2024 | In-house | $110K |
| 24/04/16for Q1 2024 | Tarplin, Downs & Young | $80K |